Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure

Department of Medicine, Mount Sinai School of Medicine of The City University of New York, New York.

To identify patients with severe chronic heart failure who are at greatest risk of developing functional renal insufficiency during converting enzyme inhibition, creatinine clearance was measured in 59 patients before and after long-term therapy with captopril (39 patients) or enalapril (20 patients), while digitalis and diuretic therapy was kept constant. Creatinine clearance increased or remained constant in 33 of the 59 patients (Group I), but declined in the remaining 26 patients (Group II). The two groups were similar with respect to the cause of heart failure, pretreatment renal function and all pretreatment hemodynamic variables. Patients in Group II, however, had lower values for serum sodium concentration (134.8 +/- 1.0 versus 137.0 +/- 0.6 mmol/liter) and higher values for plasma renin activity (10.6 +/- 3.4 versus 3.0 +/- 0.5 ng/ml per hour), received larger doses of furosemide (108 +/- 11 versus 84 +/- 6 mg/day), were more frequently diabetic (42 versus 15%) and were more frequently treated with enalapril (50 versus 21%) than were patients in Group I (all p less than 0.05). By stepwise logistic analysis, only hyponatremia (or an elevated plasma renin activity) and enalapril therapy independently predicted the decline in creatinine clearance during converting enzyme inhibition. These observations could not be explained by changes in systemic blood pressure. In patients with a normal serum sodium concentration (greater than or equal to 137 mmol/liter), creatinine clearance increased with captopril (+21%, p less than 0.05), but not with enalapril (-6%, p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				L. Balling, M. Schou, L. Videbaek, P. Hildebrandt, H. Wiggers, F. Gustafsson, and for the Danish Heart Failure Clinics Network Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure Eur J Heart Fail, September 1, 2011; 13(9): 968 - 973. [Abstract] [Full Text] [PDF]

				D. Aronson, J. G. Verbalis, M. Mueller, H. Krum, and on behalf of the DILIPO investigators Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study Eur J Heart Fail, March 1, 2011; 13(3): 327 - 336. [Abstract] [Full Text] [PDF]

				A. A. Mohammed, R. R. J. van Kimmenade, M. Richards, A. Bayes-Genis, Y. Pinto, S. A. Moore, and J. L. Januzzi Jr Hyponatremia, Natriuretic Peptides, and Outcomes in Acutely Decompensated Heart Failure: Results From the International Collaborative of NT-proBNP Study Circ Heart Fail, May 1, 2010; 3(3): 354 - 361. [Abstract] [Full Text] [PDF]

				S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, K. Michl, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation J. Am. Coll. Cardiol., April 14, 2009; 53(15): e1 - e90. [Full Text] [PDF]

				2005 WRITING COMMITTEE MEMBERS, S. A. Hunt, W. T. Abraham, M. H. Chin, A. M. Feldman, G. S. Francis, T. G. Ganiats, M. Jessup, M. A. Konstam, D. M. Mancini, et al. 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation Circulation, April 14, 2009; 119(14): e391 - e479. [Full Text] [PDF]

				L. Klein, C. M. O'Connor, J. D. Leimberger, W. Gattis-Stough, I. L. Pina, G. M. Felker, K. F. Adams Jr, R. M. Califf, M. Gheorghiade, and for the OPTIME-CHF Investigators Lower Serum Sodium Is Associated With Increased Short-Term Mortality in Hospitalized Patients With Worsening Heart Failure: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Study Circulation, May 17, 2005; 111(19): 2454 - 2460. [Abstract] [Full Text] [PDF]

				G. Marenzi, G. Lauri, E. Assanelli, M. Grazi, J. Campodonico, G. Famoso, and P. Agostoni Serum to urinary sodium concentration ratio is an estimate of plasma renin activity in congestive heart failure Eur J Heart Fail, October 1, 2002; 4(5): 597 - 603. [Abstract] [Full Text] [PDF]

				B. D. Lowes, M. Higginbotham, L. Petrovich, M. A. DeWood, M. A. Greenberg, P. S. Rahko, G. W. Dec, T. H. LeJemtel, R. L. Roden, M. M. Schleman, et al. Low-dose enoximone improves exercise capacity in chronic heart failure J. Am. Coll. Cardiol., August 1, 2000; 36(2): 501 - 508. [Abstract] [Full Text] [PDF]

				J. R. Oster and B. J. Materson Renal and Electrolyte Complications of Congestive Heart Failure and Effects of Therapy With Angiotensin-Converting Enzyme Inhibitors Arch Intern Med, April 1, 1992; 152(4): 704 - 710. [Abstract] [PDF]

				E. Marangoni, A. Oddone, M. Surian, C. Panciroli, G. Galloni, A. Masa, V. Caizzi, S. Belletti, W. R. Cominesi, and M. Orlandi Effect of High-Dose Furosemide in Refractory Congestive Heart Failure Angiology, October 1, 1990; 41(10): 862 - 868. [Abstract] [PDF]

				C. Panciroli, G. Galloni, A. Oddone, E. Marangoni, A. Masa, W. R. Cominesi, V. Caizzi, C. Pezzi, S. Belletti, C. Comalba, et al. Prognostic Value of Hyponatremia in Patients with Severe Chronic Heart Failure Angiology, August 1, 1990; 41(8): 631 - 638. [Abstract] [PDF]

				M. W. Rich and C. A. Crecelius Incidence, Risk Factors, and Clinical Course of Acute Renal Insufficiency After Cardiac Catheterization in Patients 70 Years of Age or Older: A Prospective Study Arch Intern Med, June 1, 1990; 150(6): 1237 - 1242. [Abstract] [PDF]